ArticleLifetime data analysis2021
Information measures and design issues in the study of mortality deceleration: findings for the gamma-Gompertz model.
Article in Lifetime data analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Unifying mortality forecasting model: an investigation of the COM-Poisson distribution in the GAS model for improved projections.Lifetime data analysis · 2024Article
- The AccelerAge framework: a new statistical approach to predict biological age based on time-to-event data.European journal of epidemiology · 2024Article
- Weighted Lindley frailty model: estimation and application to lung cancer data.Lifetime data analysis · 2021Article
- Longitudinal Pattern of Aerenchyma Formation Using the Ti-Gompertz Model in Rice Adventitious Roots.Frontiers in plant science · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mortality deceleration, or the slowing down of death rates at old ages, has been repeatedly investigated, but empirical studies of this phenomenon have produced mixed results. The scarcity of observations at the oldest ages complicates the statistical assessment of mortality deceleration, even in the parsimonious parametric framework of the gamma-Gompertz model considered here. The need for thorough verification of the ages at death can further limit the available data. As logistical constraints may only allow to validate survivors beyond a certain (high) age, samples may be restricted to a certain age range. If we can quantify the effects of the sample size and the age range on the assessment of mortality deceleration, we can make recommendations for study design. For that purpose, we propose applying the concept of the Fisher information and ideas from the theory of optimal design. We compute the Fisher information matrix in the gamma-Gompertz model, and derive information measures for comparing the performance of different study designs. We then discuss interpretations of these measures. The special case in which the frailty variance takes the value of zero and lies on the boundary of the parameter space is given particular attention. The changes in information related to varying sample sizes or age ranges are investigated for specific scenarios. The Fisher information also allows us to study the power of a likelihood ratio test to detect mortality deceleration depending on the study design. We illustrate these methods with a study of mortality among late nineteenth-century French-Canadian birth cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.